A role for cognitive behavioral therapy in treatment-resistant depression

Only a third of patients with depression respond fully to antidepressant drugs, and little evidence exists regarding the best next-step treatment for patients with resistant symptoms.

Researchers in the CoBalT study (Cognitive Behavioural Therapy) at the University of Bristol in England examined cognitive behavioral therapy (CBT) as an adjunct to usual care (including pharmacotherapy) for primary care patients with treatment-resistant depression compared with usual care alone. Continue reading A role for cognitive behavioral therapy in treatment-resistant depression